ANCALA BIOENERGY LIMITED - Profile & Financials

Accounts Submitted 30 Dec 2024

Confirmation Statement Submitted 9 Apr 2025

Net assets £-25.94M £12.23M 2023 year on year

Total assets £146.03M £45.62M 2023 year on year

Total Liabilities £171.97M £57.85M 2023 year on year

Charges 2

1 outstanding 1 satisfied

AI Analysis

Analyze director networks, ownership patterns, and company connections

CompanyTrack AI can make mistakes. Check important info.

Contact & Details

Contact

Update Details

Registered Address

20 Gracechurch Street London EC3V 0AF England

Office (London)

Kings House, 36 King St, London EC2V 8BB

Telephone

0208 059 0320

jowhittaker@peel.co.uk

Website

ancala.com

Credit Report

Discover ANCALA BIOENERGY LIMITED's Credit Score, limit, and payment likelihood.

Mutual Companies

See All Mutual Companies

Financials

Period 1 Jan → 31 Dec 2023

Type Total Exemption Full

Next accounts 31 December 2024

Due by 30 September 2025 9 months

Net Assets, Total Assets & Total Liabilities (2017–2023)

Cash in Bank

£17.55M

Increased by £7.99M (+84%)

Net Assets

-£25.94M

Decreased by £12.23M (-89%)

Total Liabilities

£171.97M

Increased by £57.85M (+51%)

Turnover

£64.64M

Increased by £9.31M (+17%)

Employees

176

Increased by 14 (+9%)

Debt Ratio

118%

Increased by 4 (+4%)

Financial History

Revenue, profit, EBITDA and key financial figures

	2023 Dec Year End	2022 Dec Year End
P&L
Revenue	£142.3M	£128.7M
Gross Profit	£48.2M	£43.1M
Operating Profit	£22.4M	£19.8M
Net Profit	£18.1M	£15.9M
EBITDA	£31.5M	£28.2M
Assets
Cash	£24.7M	£21.3M
Total Assets	£89.4M	£82.1M
Liabilities
Total Liabilities	£45.2M	£41.8M
Key Metrics
Employees	1,247	1,156

Latest Revenue

£142.3M

Latest EBITDA

£31.5M

Cash Position

£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Share Capital

Share allotments and capital structure

4 Allotments 3,468,286 Shares £3.47m Total

Date From	Share Class	Shares Allotted	Amount Raised	Price/Share
5 Dec 2019	ORDINARY	51,091	£51k	£1
6 Feb 2018	ORDINARY	1,279,177	£1.28m	£1
15 Jan 2018	ORDINARY	1,791,307	£1.79m	£1.79m
13 Apr 2017	ORDINARY	346,711	£347k	£1

Officers

4 active 11 resigned

Show resigned officers

						Status
Adam Feneley	Director	British	United Kingdom	45	24 Nov 2023	Active
Cathryn Lister	Director	British	England	43	1 Dec 2018	Active
Luke William Ford	Director	British	England	38	3 Feb 2025	Active
Matthew John Hughes	Director	British	England	48	15 Aug 2024	Active

Shareholders

Shareholders (2)


Ancala Bioenergy Investco Limited	100.0%	3,468,287	Ordinary	9 Apr 2020
Ancala Bioenergy Midco Ltd	0.0%	0	Ordinary	9 Apr 2020

Persons with Significant Control

Persons with Significant Control (1)

1 Active 1 Ceased

Ancala Bioenergy Investco Limited

United Kingdom

Active

Notified 6 Mar 2020

Nature of Control

Ownership Of Shares 75 To 100 Percent
Voting Rights 75 To 100 Percent

Ancala Bioenergy Midco Limited

Ceased 6 Mar 2020

Ceased

See All Controllers

Group Structure

ANCALA BIOENERGY INVESTCO LIMITED united kingdom shares 75 to 100 percent, voting rights 75 to 100 percent, appoint/remove directors

ANCALA BIOENERGY MIDCO LIMITED united kingdom shares 75 to 100 percent, voting rights 75 to 100 percent, appoint/remove directors

ANCALA BIOENERGY HOLDCO LIMITED united kingdom shares 75 to 100 percent, voting rights 75 to 100 percent, appoint/remove directors

ANCALA ESSENTIAL GROWTH INFRASTRUCTURE GP LLP united kingdom voting rights 25 to 50 percent limited liability partnership, right to share surplus assets 25 to 50 percent limited liability partnership

ANCALA PARTNERS LLP united kingdom voting rights 25 to 50 percent limited liability partnership, right to share surplus assets 25 to 50 percent limited liability partnership

ANCALA MEMBER LIMITED united kingdom shares 75 to 100 percent, voting rights 75 to 100 percent

LACANN LIMITED united kingdom

VONTOBEL ASSET MANAGEMENT UK 2 HOLDINGS LTD. united kingdom shares 75 to 100 percent, voting rights 75 to 100 percent, appoint/remove directors

VONTOBEL HOLDING AG switzerland

ANCALA BIOENERGY LIMITED Current Company

BIOGEN BIOENERGY LIMITED united kingdom shares 75 to 100 percent, voting rights 75 to 100 percent, appoint/remove directors

BIOGEN EM TOPCO LIMITED united kingdom shares 75 to 100 percent, voting rights 75 to 100 percent, appoint/remove directors

BIOGEN HOLDINGS LIMITED united kingdom shares 75 to 100 percent, voting rights 75 to 100 percent, appoint/remove directors

BIOGEN SOUTHERN LIMITED united kingdom shares 75 to 100 percent, voting rights 75 to 100 percent, appoint/remove directors

TAMAR ENERGY LIMITED united kingdom shares 75 to 100 percent, voting rights 75 to 100 percent, appoint/remove directors

Charges

1 outstanding 1 satisfied

Documents

Company Filings

Date	Category	Description	Document
28 Jul 2025	Officers	Termination of Graeme Kenneth Charles Vincent as director on 2025-07-22	View(1 page)
9 Apr 2025	Confirmation Statement	Confirmation statement made on 2025-03-28 with no updates	View(3 pages)
3 Feb 2025	Officers	Appointment of Mr Luke William Ford as director on 2025-02-03	View(2 pages)
30 Dec 2024	Accounts	Annual accounts made up to 2024-03-31	View(46 pages)
9 Sept 2024	Persons With Significant Control	Change to Ancala Bioenergy Investco Limited as a person with significant control on 2024-09-09	View(2 pages)